TiVo (TIVO) Forms $14.95 Double Bottom; Daruma Capital Management Decreased Its Natus Medical Del (BABY) Position

TiVo Corporation (NASDAQ:TIVO) Logo

TiVo Corporation (TIVO) formed double bottom with $14.05 target or 6.00% below today’s $14.95 share price. TiVo Corporation (TIVO) has $1.84B valuation. The stock increased 2.75% or $0.4 during the last trading session, reaching $14.95. About 1.03 million shares traded. TiVo Corporation (NASDAQ:TIVO) has declined 24.65% since April 17, 2017 and is downtrending. It has underperformed by 36.20% the S&P500.

Daruma Capital Management Llc decreased Natus Medical Inc Del (BABY) stake by 6.49% reported in 2017Q4 SEC filing. Daruma Capital Management Llc sold 89,896 shares as Natus Medical Inc Del (BABY)’s stock declined 13.23%. The Daruma Capital Management Llc holds 1.30 million shares with $49.49 million value, down from 1.39 million last quarter. Natus Medical Inc Del now has $1.15 billion valuation. It closed at $35.05 lastly. It is down 13.34% since April 17, 2017 and is downtrending. It has underperformed by 24.89% the S&P500.

Among 11 analysts covering TiVo (NASDAQ:TIVO), 5 have Buy rating, 0 Sell and 6 Hold. Therefore 45% are positive. TiVo has $3100 highest and $8 lowest target. $17.80’s average target is 19.06% above currents $14.95 stock price. TiVo had 29 analyst reports since September 8, 2015 according to SRatingsIntel. FBR Capital upgraded the stock to “Buy” rating in Friday, February 16 report. On Wednesday, September 20 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating by M Partners given on Wednesday, November 25. Albert Fried downgraded the shares of TIVO in report on Monday, May 2 to “Market Perform” rating. Topeka Capital Markets maintained TiVo Corporation (NASDAQ:TIVO) on Tuesday, September 8 with “Buy” rating. The rating was initiated by BWS Financial with “Buy” on Monday, January 22. Topeka Capital Markets downgraded it to “Hold” rating and $11 target in Monday, May 2 report. The company was downgraded on Thursday, January 11 by FBR Capital. The rating was maintained by B. Riley & Co with “Buy” on Monday, October 30. Jefferies maintained it with “Buy” rating and $1800 target in Friday, August 11 report.

Analysts await TiVo Corporation (NASDAQ:TIVO) to report earnings on May, 2. They expect $0.33 EPS, up 50.00% or $0.11 from last year’s $0.22 per share. TIVO’s profit will be $40.57M for 11.33 P/E if the $0.33 EPS becomes a reality. After $0.25 actual EPS reported by TiVo Corporation for the previous quarter, Wall Street now forecasts 32.00% EPS growth.

Daruma Capital Management Llc increased Superior Energy Svcs Inc (NYSE:SPN) stake by 217,957 shares to 437,577 valued at $4.21 million in 2017Q4. It also upped Green Plains Inc (NASDAQ:GPRE) stake by 3.30 million shares and now owns 3.45 million shares. Monotype Imaging Holdings In (NASDAQ:TYPE) was raised too.

Investors sentiment decreased to 0.71 in Q4 2017. Its down 0.05, from 0.76 in 2017Q3. It dropped, as 19 investors sold BABY shares while 78 reduced holdings. 27 funds opened positions while 42 raised stakes. 30.91 million shares or 1.01% more from 30.60 million shares in 2017Q3 were reported. Sei Investments reported 7,832 shares. Callahan Ltd holds 0.05% or 5,935 shares in its portfolio. Ohio-based Fort Washington Inv Oh has invested 0.1% in Natus Medical Incorporated (NASDAQ:BABY). Paloma Prns Co has invested 0.01% in Natus Medical Incorporated (NASDAQ:BABY). Contravisory Inc invested in 0% or 27 shares. Teachers Ins And Annuity Association Of America invested 0.06% in Natus Medical Incorporated (NASDAQ:BABY). Goldman Sachs Grp Inc owns 109,916 shares for 0% of their portfolio. Schwab Charles Invest Mngmt Inc has 0% invested in Natus Medical Incorporated (NASDAQ:BABY). Dekabank Deutsche Girozentrale invested in 0% or 13,000 shares. Alphaone Investment Ser reported 63,824 shares. Impax Asset Management Ltd holds 1.77% in Natus Medical Incorporated (NASDAQ:BABY) or 804,722 shares. Etrade Management Llc holds 34,886 shares or 0.04% of its portfolio. Northwestern Mutual Wealth Mgmt holds 0% of its portfolio in Natus Medical Incorporated (NASDAQ:BABY) for 49 shares. Price T Rowe Associate Inc Md holds 397,085 shares or 0% of its portfolio. 11 are owned by Assetmark Inc.

Analysts await Natus Medical Incorporated (NASDAQ:BABY) to report earnings on April, 25 before the open. They expect $0.24 earnings per share, down 20.00% or $0.06 from last year’s $0.3 per share. BABY’s profit will be $7.87 million for 36.51 P/E if the $0.24 EPS becomes a reality. After $0.42 actual earnings per share reported by Natus Medical Incorporated for the previous quarter, Wall Street now forecasts -42.86% negative EPS growth.

Natus Medical Incorporated (NASDAQ:BABY) Institutional Positions Chart